Cargando…
Clinical Relevance of the Serial Measurement of Krebs von den Lungen-6 Levels in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
Krebs von den Lungen-6 (KL-6) levels measured at baseline have been reported as a circulating biomarker useful for the detection, evaluation of severity and assessment of risk of the progression of interstitial lung disease (ILD) in patients with systemic sclerosis (SSc). In this retrospective study...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619247/ https://www.ncbi.nlm.nih.gov/pubmed/34829353 http://dx.doi.org/10.3390/diagnostics11112007 |
_version_ | 1784604943828647936 |
---|---|
author | Shirai, Yuichiro Fukue, Ryosuke Kaneko, Yuko Kuwana, Masataka |
author_facet | Shirai, Yuichiro Fukue, Ryosuke Kaneko, Yuko Kuwana, Masataka |
author_sort | Shirai, Yuichiro |
collection | PubMed |
description | Krebs von den Lungen-6 (KL-6) levels measured at baseline have been reported as a circulating biomarker useful for the detection, evaluation of severity and assessment of risk of the progression of interstitial lung disease (ILD) in patients with systemic sclerosis (SSc). In this retrospective study, longitudinal changes in serum KL-6 levels over 2 years were examined in 110 patients with SSc using prospectively collected cohort data. Serum KL-6 levels fluctuated in a significant proportion of the patients but remained stable in the remaining patients. A wide range of variability of longitudinal KL-6 levels was associated with the presence of ILD, diffuse cutaneous SSc, positive anti-topoisomerase I antibodies, negative anticentromere antibodies, increased ILD extent on high-resolution computed tomography, extensive disease, low pulmonary function parameters, high KL-6 levels at baseline and immunomodulatory treatment. Extensive disease was consistently identified as an independent factor associated with variability in KL-6 levels in different models of multiple regression analysis. We failed to demonstrate correlations between trends for KL-6 level changes during the 6 months after SSc diagnosis and ILD progression over 2 years in patients with SSc-ILD. Serum KL-6 levels fluctuate in SSc patients with ILD, especially in those with extensive disease, but the clinical utility of a serial KL-6 level measurement remains uncertain. |
format | Online Article Text |
id | pubmed-8619247 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86192472021-11-27 Clinical Relevance of the Serial Measurement of Krebs von den Lungen-6 Levels in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease Shirai, Yuichiro Fukue, Ryosuke Kaneko, Yuko Kuwana, Masataka Diagnostics (Basel) Article Krebs von den Lungen-6 (KL-6) levels measured at baseline have been reported as a circulating biomarker useful for the detection, evaluation of severity and assessment of risk of the progression of interstitial lung disease (ILD) in patients with systemic sclerosis (SSc). In this retrospective study, longitudinal changes in serum KL-6 levels over 2 years were examined in 110 patients with SSc using prospectively collected cohort data. Serum KL-6 levels fluctuated in a significant proportion of the patients but remained stable in the remaining patients. A wide range of variability of longitudinal KL-6 levels was associated with the presence of ILD, diffuse cutaneous SSc, positive anti-topoisomerase I antibodies, negative anticentromere antibodies, increased ILD extent on high-resolution computed tomography, extensive disease, low pulmonary function parameters, high KL-6 levels at baseline and immunomodulatory treatment. Extensive disease was consistently identified as an independent factor associated with variability in KL-6 levels in different models of multiple regression analysis. We failed to demonstrate correlations between trends for KL-6 level changes during the 6 months after SSc diagnosis and ILD progression over 2 years in patients with SSc-ILD. Serum KL-6 levels fluctuate in SSc patients with ILD, especially in those with extensive disease, but the clinical utility of a serial KL-6 level measurement remains uncertain. MDPI 2021-10-28 /pmc/articles/PMC8619247/ /pubmed/34829353 http://dx.doi.org/10.3390/diagnostics11112007 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Shirai, Yuichiro Fukue, Ryosuke Kaneko, Yuko Kuwana, Masataka Clinical Relevance of the Serial Measurement of Krebs von den Lungen-6 Levels in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease |
title | Clinical Relevance of the Serial Measurement of Krebs von den Lungen-6 Levels in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease |
title_full | Clinical Relevance of the Serial Measurement of Krebs von den Lungen-6 Levels in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease |
title_fullStr | Clinical Relevance of the Serial Measurement of Krebs von den Lungen-6 Levels in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease |
title_full_unstemmed | Clinical Relevance of the Serial Measurement of Krebs von den Lungen-6 Levels in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease |
title_short | Clinical Relevance of the Serial Measurement of Krebs von den Lungen-6 Levels in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease |
title_sort | clinical relevance of the serial measurement of krebs von den lungen-6 levels in patients with systemic sclerosis-associated interstitial lung disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619247/ https://www.ncbi.nlm.nih.gov/pubmed/34829353 http://dx.doi.org/10.3390/diagnostics11112007 |
work_keys_str_mv | AT shiraiyuichiro clinicalrelevanceoftheserialmeasurementofkrebsvondenlungen6levelsinpatientswithsystemicsclerosisassociatedinterstitiallungdisease AT fukueryosuke clinicalrelevanceoftheserialmeasurementofkrebsvondenlungen6levelsinpatientswithsystemicsclerosisassociatedinterstitiallungdisease AT kanekoyuko clinicalrelevanceoftheserialmeasurementofkrebsvondenlungen6levelsinpatientswithsystemicsclerosisassociatedinterstitiallungdisease AT kuwanamasataka clinicalrelevanceoftheserialmeasurementofkrebsvondenlungen6levelsinpatientswithsystemicsclerosisassociatedinterstitiallungdisease |